Learn about d-Wise's newest offering, Blur! Our De-Identification and Anonymization program to help keep all of your records and user information private.

1. © d-Wise 2015 Page ‹#›
d-Wise
De-Identification and Anonymization
empowering innovation for a healthier world

2. © d-Wise 2015 Page ‹#›
Put people in
the center of
the picture
Define
actionable
solutions
Achieve
success
through small
steps
Manage
change &
expect to adapt
We are a global technology consulting firm focused
on simplifying the life sciences enterprise
Life Science Clients Partners

3. © d-Wise 2015 Page ‹#›
Our Services
Helping clients navigate
standards adoption
• CDISC Standards
• Standards Governance
• People, process, and
technology
• Development, Use and
Maintenance
Standards
Enabling the business by
leveraging technology
• MDR, CDR, EDC, SCE
• System Integration
• Industry Product
Development
• Custom Development
• Technology selection
and implementation
Technology
Aligning strategy and
execution for success
• Gap Analysis
• Process Optimization
• Organizational Design
• SOP Development
• Matching processes to
organizational goals
Process
EXECUTION | PROGRAM & PROJECT MANAGEMENT | ORGANIZATIONAL CHANGE
STRATEGY | ADVISORY | IMPLEMENTATION

4. © d-Wise 2015 Page ‹#›
The d-Wise
De-Identification Solution
Blur is the industry-leading solution for
delivering de-identified clinical trial data
and protecting patient privacy
“As we expand the availability and sharing of our patient-level clinical trial
data to support the improvement of healthcare, we decided to streamline
our processes further. d-Wise’s software solution will help us to achieve this
in a way that continues to safeguard the quality of the data.”
James Armbrust, AstraZeneca Head, Clinical Trial Transparency & Disclosure

5. © d-Wise 2015 Page ‹#›
Challenges of Patient-Level Data De-
Identification
 Historically, de-identification has been a low volume,
low visibility process
– Minimally maintained tools
– Drop-in resourcing
– Low priority work
– No automation
 Growing interest in sharing de-identified data
internally and externally is stressing existing
processes
Public sensitivity to privacy has
never been higher

6. © d-Wise 2015 Page ‹#›
The Value of d-Wise Blur
Reduced
de-id costs
• 90% reduction
for
standardized
data
• 70% reduction
for other trials
• Decreased
outsourcing
Designed for
clinical trials
• Understands
CDISC, SAS and
other data types
• Supports PhUSE
and emerging
rules
• Integrated
workflow controls
process
• Audit trail
captures data
activities
Reduced
IT costs
• Internal
development is
time-consuming
• SAS Macro
maintenance is
challenging
• COTS application
enables industry
alignment

7. © d-Wise 2015 Page ‹#›
Blur Capabilities
Application-Driven with Zero Coding
Integrated Workflow and Controls
Rapid Replication Across Projects
Designed for clinical trials

8. © d-Wise 2015 Page ‹#›
 There is tremendous growth in the need to de-
identify clinical trial data
 Existing tools and approaches are too time-
consuming, too labor-intensive and too costly
Blur will enable you to deliver high-quality de-identified
clinical trial data to your internal and external
collaborators at lower cost and with faster turnaround
time than any other approach available today.